Monday, 21 October 2019

Tiyanyin Pharma recieves GMP certification

08 July 2014 | News | By BioSpectrum Bureau

TPI announced that the regulatory quality and pricing tests were conducted by the China Food and Drug Administration (CFDA)

TPI announced that the regulatory quality and pricing tests were conducted by the China Food and Drug Administration (CFDA)

Singapore: China-based Tianyin Pharmaceutical has received good manufacturing practice (GMP) certification under certificate number Chuan K0592, valid until December 31, 2015 for its tablets manufacturing division.

In April 2014, TPI announced that the regulatory quality and pricing tests were conducted by the China Food and Drug Administration (CFDA) of Sichuan province, which resulted in the company's GMP certificate being temporarily administrated by the provincial CFDA. As a result, production and sale of certain of the Company's products were temporarily halted, pending the results of quality and pricing tests.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls